This activity is intended for cardiologists, interventional cardiologists, vascular medicine specialists, cardiothoracic, endovascular, vascular and general surgeons, interventional radiologists, osteopaths, family physicians, internists, endocrinologists, podiatrists, physical medicine and rehabilitation, residents and fellows, diabetes & wound care specialists, advanced practice nurses, physician assistants, nurses, radiology technologists, physical therapists, paramedics, EMTs and healthcare administrators.
Statement of Need/Program Overview
This program highlights the benefits of the multidisciplinary approach to patient care, which includes primary care physicians, nurses, podiatrists, surgeons, wound care specialists and lab technicians. PAD, CLI, coronary artery disease and stroke are very complex diseases that require the collaborative efforts of a multidisciplinary team to treat successfully. The audience represents the different healthcare fields that need to come together to raise awareness among patients about CVD symptoms, the importance of follow-up care and the dangers that not seeking treatment may lead to, including stroke, amputation and death.
Upon completion of this activity, participants will be able to:
- Discuss the indications, risks and complications of interventional therapies in the treatment of cardiovascular disease, peripheral artery disease, and critical limb ischemia.
- Understand and implement contemporary approaches in peripheral vascular management (including carotid, renal and mesenteric, SFA, below the knee, venous disease and aortic) based on recent clinical trials and evidenced-based data.
- Apply appropriate applications of new endovascular technologies for patients with vascular disease.
- Describe appropriate pharmacologic management in the care of patients with cardiovascular disease, peripheral artery disease and critical limb ischemia.
- Discuss various testing modalities and comprehensive spectrum of care in patients with foot ulcers and threatened limbs.
- Explain proper use and interpretation of diagnostic tools and apply appropriate screening techniques for peripheral artery disease.
- Recognize the roles and responsibilities of multidisciplinary members of a comprehensive PAD clinical team.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and New Cardiovascular Horizons Foundation (NCVH). ACHL is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit DesignationAcademy for Continued Healthcare Learning designates this live activity for a maximum of 23.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
This Provider approved by the California Board of Registered Nursing, Provider Number 14803 for 23.25 contact hours.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by ACCME or a recognized state medical society.
Council on Podiatric Medical Education
The NCVH 2018 Annual Conference is sponsored by the Ohio Foot and Ankle Medical Foundation. The Ohio Foot and Ankle Medical Foundation is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. Total continuing education contact hours is 24.5. Podiatrists should claim only the credits commensurate with the extent of their participation in New Cardiovascular Horizons Annual Conference.
American Society of Radiologic Technologists (ASRT)
This activity has been has been planned and implemented in accordance with the American Society of Radiologic Technologists.
Disclosure of Conflicts of InterestACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
ACHL staff members, NCVH staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Disclosure of Unlabeled Use
The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
DisclaimerParticipants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Certificate InstructionsPhysical (paper) accreditation certificates will not be issued at this meeting.
Participants will receive an email from firstname.lastname@example.org within ten (10) business days after the meeting with a link to complete the required evaluation and download certificates in PDF format. Certificates will also be available for download in the NCVH user portal at ncvh.org/login.
For questions or assistance, please contact us at email@example.com or 337.993.7920.
Photography and VideoPlease be advised that photographs and/or video may be taken at the meeting for use:
• On the conference website and on conference social media pages.
• In the press, including marketing materials and publications distributed to the public.
By entering the meeting, you consent to the use of your image and likeness for the purposes mentioned above.